Amgen, Pfizer led TrumpRx firms in 2025 lobbying
The 17 pharmaceutical companies taking part in the White House's discount prescription drug program spent more than $130 million last year on federal lobbying.
The 17 pharmaceutical companies taking part in the White House's discount prescription drug program spent more than $130 million last year on federal lobbying.
